Violation Tracker Parent Company Summary
|Top 5 Offense Groups (Groups Defined)||Penalty Total||Number of Records|
|Top 5 Primary Offense Types||Penalty Total||Number of Records|
|off-label or unapproved promotion of medical products||$3,004,361,860||4|
|drug or medical equipment safety violation||$880,750,000||4|
|False Claims Act and related||$383,656,216||12|
|kickbacks and bribery||$125,000,000||2|
|price-fixing or anti-competitive practices||$27,500,000||3|
Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. The totals are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below.
BLOCK DRUG; GLAXO SMITH KLINE; GLAXOSMITH KLINE; GlaxoSmithKline; GLAXOSMITHKLINE COLLEGEVILLE FAC; GLAXOSMITHKLINE PLC; GLAXOSMITHKLINE VACCINES; SB Pharmco Puerto Rico Inc.; SmithKline Beecham Corp.
For an overview of this company's accountability track record, read its Corporate Rap Sheet here.
For more details on misconduct by this company, see its entry in the Project On Government Oversight's Federal Contractor Misconduct Database.
For a summary of this company's federal contracts, see its page on Fedspending.
Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found here.
For an overview of assistance this company is receiving under the CARES Act, see its Covid Stimulus Watch summary page here.
Individual Penalty Records:Click on the company or penalty amount for more information on each case.
|Company||Primary Offense Type||Year||Agency||Penalty Amount|
|GlaxoSmithKline LLC||off-label or unapproved promotion of medical products||2012||FDA||$3,000,000,000|
|SB Pharmco Puerto Rico Inc.||drug or medical equipment safety violation||2010||FDA||$750,000,000|
|GlaxoSmithKline||off-label or unapproved promotion of medical products||2012||MULTI-AG||(*) $477,792,391|
|SB Pharmco Puerto Rico Inc.||drug or medical equipment safety violation||2010||MULTI-AG||(*) $163,560,000|
|GlaxoSmithKline||False Claims Act and related||2005||DOJ_CIVIL||$150,000,000|
|GlaxoSmithKline, LLC||kickbacks and bribery||2014||MULTI-AG||$105,000,000|
|GlaxoSmithKline LLC||drug or medical equipment safety violation||2012||MULTI-AG||$90,000,000|
|GlaxoSmithKline||False Claims Act and related||2006||MULTI-AG||$70,000,000|
|GlaxoSmithKline LLC||False Claims Act and related||2019||IL-AG||$54,653,931|
|SmithKline Beecham||False Claims Act and related||2003||DOJ_CIVIL||$47,000,000|
|GlaxoSmithKline, LLC||drug or medical equipment safety violation||2011||MULTI-AG||$40,750,000|
|GlaxoSmithKline||False Claims Act and related||2003||MULTI-AG||$40,000,000|
|GlaxoSmithKline plc||kickbacks and bribery||2016||SEC||$20,000,000|
|GlaxoSmithKline||price-fixing or anti-competitive practices||2006||MULTI-AG||$14,000,000|
|GlaxoSmithKline||False Claims Act and related||2005||MULTI-AG||(*) $10,000,000|
|GlaxoSmithKline||False Claims Act and related||2012||LA-AG||$10,000,000|
|SmithKline Beecham Corp.||price-fixing or anti-competitive practices||2005||MULTI-AG||$10,000,000|
|GlaxoSmithKline||False Claims Act and related||2011||KS-AG||$4,250,000|
|GlaxoSmithKline||off-label or unapproved promotion of medical products||2010||KY-AG||$3,700,000|
|GlaxoSmithKline||price-fixing or anti-competitive practices||2006||MULTI-AG||$3,500,000|
|GlaxoSmithKline LLC||False Claims Act and related||2010||HI-AG||$3,333,333|
|GlaxoSmithKline||False Claims Act and related||2012||ID-AG||$2,600,000|
|SmithKline Beecham Corp.||False Claims Act and related||2007||TX-AG||$1,400,000|
|GlaxoSmithKline||off-label or unapproved promotion of medical products||2009||KY-AG||$661,860|
|GlaxoSmithKline||False Claims Act and related||2006||GA-AG||$418,952|
|Block Drug Company Incorporated||wage and hour violation||2011||WHD||$352,773|
|GlaxoSmithKline LLC||environmental violation||2014||EPA||$317,550|
|GLAXOSMITHKLINE, LLC||environmental violation||2014||EPA||(*) $317,550|
|GlaxoSmithKline Vaccines||environmental violation||2014||EPA||$172,900|
|GLAXOSMITHKLINE VACCINES||environmental violation||2014||EPA||(*) $172,900|
|GLAXOSMITH KLINE||environmental violation||2014||EPA||$90,000|
|GLAXO SMITH KLINE||aviation safety violation||2014||FAA||$59,500|
|GLAXOSMITHKLINE COLLEGEVILLE FAC||environmental violation||2017||EPA||$5,259|